Edition:
United Kingdom

X T L Biopharmaceuticals Ltd (XTLB.OQ)

XTLB.OQ on NASDAQ Stock Exchange Capital Market

2.34USD
14 Dec 2017
Change (% chg)

$0.03 (+1.30%)
Prev Close
$2.31
Open
$2.33
Day's High
$2.34
Day's Low
$2.33
Volume
1,048
Avg. Vol
1,957
52-wk High
$4.69
52-wk Low
$1.93

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.003
Jun '17 -0.003
Mar '17 -0.003
FY 2016 Dec '16 0.00 -0.003
Sep '16 -0.001
Jun '16 0.00 -0.002
Mar '16 -0.002
FY 2015 Dec '15 0.00 -0.007
Sep '15 0.00 -0.002
Jun '15 0.00 -0.001
Mar '15 -0.002
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.65 32.93
P/E High - Last 5 Yrs. 329.55 290.75 45.62
P/E Low - Last 5 Yrs. 329.55 93.66 24.34
Beta -0.08 0.85 0.88
Price to Sales (TTM) -- 100.67 5.40
Price to Book (MRQ) 0.67 13.50 5.38
Price to Tangible Book (MRQ) 6.40 13.43 6.78
Price to Cash Flow (TTM) -- 76.23 23.45
% Owned Institutions 1.12 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 433.84 9.00
Sales (TTM) vs TTM 1 Yr. Ago -- 75.03 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -34.50 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago 21.36 -- --
EPS - 5 Yr. Growth Rate -- 43.17 10.79
Capital Spending - 5 Yr. Growth Rate 40.63 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 17.78 5.36 2.98
LT Debt to Equity (MRQ) -- 18.92 11.56
Total Debt to Equity (MRQ) -- 20.59 15.81
Interest Coverage (TTM) -- -112.49 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -261.11 15.24
Operating Margin (TTM) -- -556.64 7.76
Operating Margin - 5 Yr. Avg. -- -279.29 10.75
Pre-Tax Margin (TTM) -- -529.88 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -279.02 11.17
Net Profit Margin (TTM) -- -531.33 4.88
Net Profit Margin - 5 Yr. Avg. -- -282.20 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 25,314,503 864,673,321
Net Income/Employee (TTM) -- 3,332,048 101,717,508
Receivable Turnover (TTM) -- 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.00 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -67.01 -0.78 11.00
Return on Assets - 5 Yr. Avg. -30.54 -0.26 12.43
Return on Investment (TTM) -70.95 2.35 14.46
Return on Investment - 5 Yr. Avg. -39.11 2.98 16.28
Return on Equity (TTM) -125.01 2.95 16.05
Return on Equity - 5 Yr. Avg. -32.85 6.40 17.51
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 32.39 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for X T L Biopharmaceuticals Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.06%
# of Holders: 5
Total Shares Held: 105,712
3 Mo. Net Change: -7,959
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 2
# Reduced Positions: 2
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.